Nobody mentioned my gallbladder when I started reading about menopause. It felt like a complete non-sequitur when a friend ended up in surgery two years after her last period. Then another friend. Looking into it properly, the estrogen-bile link is one of those things that makes you wish someone had just explained the plumbing earlier — it's not scary, it's just useful to know.
Learn more about Rose →Estrogen stimulates the liver to secrete more cholesterol into bile, which shifts the balance of bile toward a cholesterol-saturated state. When bile contains more cholesterol than bile salts and lecithin can keep dissolved, crystals begin to form — and those crystals are the starting point for gallstones. This mechanism is well-established and explains why gallstone risk tracks closely with estrogen exposure across a woman's life.
Beyond changing bile composition, estrogen reduces the contractile force of the gallbladder muscle, meaning bile sits in the gallbladder for longer between meals. Stagnant bile gives cholesterol crystals more time to aggregate into stones — a process sometimes called biliary sludge before stones fully form. This sluggish emptying effect has been observed both in pregnancy (high estrogen) and with oral estrogen use.
Counterintuitively, it's not just high estrogen that causes problems — the withdrawal of estrogen at menopause also destabilises bile chemistry that the body had adapted to over decades. Bile salt composition shifts, the gut motility that moves bile along slows, and cholesterol metabolism changes all at once. The gallbladder, in short, gets handed a new set of operating conditions with no transition period.
When estrogen is taken orally, it passes through the liver in high concentrations before entering general circulation — a process called first-pass metabolism. This direct hepatic exposure amplifies the cholesterol-secretion effect in bile far more than estrogen absorbed through the skin, which bypasses the liver. Multiple large studies, including analysis from the Women's Health Initiative, found that oral but not transdermal estrogen significantly raised gallbladder disease risk.
The metabolic shift that drives weight gain — particularly visceral fat — around menopause independently increases cholesterol output from the liver into bile. More cholesterol in circulation means more cholesterol available to saturate bile, stacking on top of the hormonal changes already at work. Women who gain significant abdominal weight during the menopause transition carry a compounded gallstone risk that goes beyond hormones alone.
Insulin resistance, which becomes more common after menopause, impairs the normal recycling loop of bile acids between the gut and liver. When this enterohepatic circulation slows, the pool of bile acids available to keep cholesterol dissolved in bile shrinks, tilting the balance further toward stone formation. This is one reason type 2 diabetes and metabolic syndrome are both established risk factors for gallstones.
When the body loses weight quickly, it mobilises fat rapidly, and the liver responds by excreting more cholesterol into bile — often faster than bile salts can compensate. Gallbladder emptying also slows during calorie restriction, creating exactly the stagnant, cholesterol-rich environment where stones form. This risk applies to crash diets, bariatric surgery, and increasingly to GLP-1 receptor agonists like semaglutide, which are being used more widely in midlife women.
Progesterone, like estrogen, reduces the contractility of smooth muscle — including the gallbladder wall — which is why many women notice digestive sluggishness in the luteal phase of their cycle. In perimenopause, erratic progesterone levels can contribute to unpredictable gallbladder emptying patterns. Women on combined HRT with synthetic progestogens may find this effect persists, though natural progesterone appears to have a more neutral impact on bile than synthetic versions.
Gallbladder pain typically presents as a dull ache or intense cramping in the upper right abdomen, sometimes radiating to the right shoulder — but milder biliary dysfunction can look like bloating, nausea, or general digestive discomfort that many women attribute to menopause itself. This overlap means gallbladder disease goes unrecognised for longer in midlife women, sometimes until a stone causes a more serious blockage. Any new or persistent upper abdominal pain, especially after fatty meals, is worth investigating with an ultrasound rather than assuming it's hormonal.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.